GC Cell Corp banner
G

GC Cell Corp
KOSDAQ:144510

Watchlist Manager
GC Cell Corp
KOSDAQ:144510
Watchlist
Price: 24 350 KRW -1.02% Market Closed
Market Cap: ₩384.7B

Gross Margin

16.9%
Current
Declining
by 7.5%
vs 3-y average of 24.4%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
16.9%
=
Gross Profit
₩28.7B
/
Revenue
₩170.1B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
16.9%
=
Gross Profit
₩28.7B
/
Revenue
₩170.1B

Peer Comparison

Country Company Market Cap Gross
Margin
KR
GC Cell Corp
KOSDAQ:144510
365.9B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
399.2B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
202.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
188.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
AU
CSL Ltd
ASX:CSL
71.4B AUD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
43nd
Based on 2 511 companies
43nd percentile
16.9%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

GC Cell Corp
Glance View

Market Cap
384.7B KRW
Industry
Biotechnology

GC Cell Corp. engages in the research and development of cell curing agents and in the transport and sale of consignment inspection samples. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2016-06-23. The firm operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.

Intrinsic Value
31 091.34 KRW
Undervaluation 22%
Intrinsic Value
Price
G
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
16.9%
=
Gross Profit
₩28.7B
/
Revenue
₩170.1B
What is GC Cell Corp's current Gross Margin?

The current Gross Margin for GC Cell Corp is 16.9%, which is below its 3-year median of 24.4%.

How has Gross Margin changed over time?

Over the last 3 years, GC Cell Corp’s Gross Margin has decreased from 45.8% to 16.9%. During this period, it reached a low of 16.8% on Jun 30, 2025 and a high of 45.8% on Sep 30, 2022.

Back to Top